Acción 4530 HISAMITSU PHARMACEUTICAL CO., INC.
Añadir a una lista
Para utilizar esta función debe ser un cliente o miembro.
ConéctateRegístrate

Otros idiomas Hisamitsu Pharmaceutical Co., Inc.

Acciones

4530

JP3784600003

Mercado cerrado - Japan Exchange
Otros sitios de cotización
 08:00:00 02/05/2024 		Varia. Cinco días. Varia. 1 de enero.
3.740 JPY -2,07 % Gráfico intradía de Hisamitsu Pharmaceutical Co., Inc. -1,03 % -13,25 %
11/04 El beneficio atribuible a Hisamitsu Pharmaceutical aumenta un 19% en el ejercicio fiscal 2024 MT
11/01 Hisamitsu Pharmaceutical Co., Inc. proporciona una guía de ganancias consolidadas para el año fiscal que finaliza el 29 de febrero de 2024 CI

Otros idiomas

Buscar
Ver los resultados
Desbloquee todas las noticias sobre todas las empresas: ¡No vuelvas a perderse una oportunidad de inversión rentable!
Inscripción 100% Gratuita
Hisamitsu Pharmaceutical : Notice of Convocation of the 122nd Annual General Meeting of Shareholders
Hisamitsu Pharmaceutical Attributable Profit Up 19% in Fiscal 2024
Hisamitsu Pharmaceutical : Earning Document
Hisamitsu Pharmaceutical : Notification of Completion of Construction of the New Research Laboratory “SAGA Global Research Center”
Hisamitsu Pharmaceutical Lifts Fiscal-Year Targets as Nine-Month Profit, Net Sales Rise
Hisamitsu Pharmaceutical Co., Inc. Provides Consolidated Earnings Guidance for the Fiscal Year Ending February 29, 2024
Hisamitsu Pharmaceutical Co., Inc. Announces Dividend for the Second Quarter and Provides Dividend Guidance for the Full Year Ending February 29, 2024
Tranche Update on Hisamitsu Pharmaceutical Co., Inc.'s Equity Buyback Plan announced on July 13, 2023.
Hisamitsu Pharmaceutical Co., Inc.'s Equity Buyback announced on July 13, 2023, has closed with 2,000,000 shares, representing 2.58% for ¥9,792.58 million.
Tranche Update on Hisamitsu Pharmaceutical Co., Inc.'s Equity Buyback Plan announced on July 13, 2023.
Hisamitsu Pharmaceutical : Notice Regarding Status of Acquisition of Treasury Shares
Hisamitsu Pharmaceutical : Announcement regarding completion of partial transfer of assets, related to S-Cup and Lacalut from SSP Co., Ltd.
Hisamitsu Pharmaceutical’s Attributable Profit up 29.4% in Fiscal Q2 on Improved Net Sales
Hisamitsu Pharmaceutical : Earning Document
Hisamitsu Pharmaceutical : Earning Document
Hisamitsu Pharmaceutical Co., Inc. Reports Earnings Results for the Half Year Ended August 31, 2023
Hisamitsu Pharmaceutical : Notification regarding Skin Care Cosmetics with Microneedle Technology
Hisamitsu Pharmaceutical : Notification of the commencement of the Phase II clinical study of HP-6050 in Japan (a transdermal formulation for sedation)
Tranche Update on Hisamitsu Pharmaceutical Co., Inc.'s Equity Buyback Plan announced on July 13, 2023.
Hisamitsu Pharmaceutical : Notice Regarding Status of Acquisition of Treasury Shares
No hay resultados para esta búsqueda
Todas Recomendaciones analistas Eventos destacados Insiders Transcripts Comunicados Publs. oficiales Otros idiomas Ideas de trading Artículos de MarketScreener Estrategias MarketScreener

Filtros

Buscar

Fecha de publicación

De

Hasta

  1. Bolsa de valores
  2. Acciones
  3. Acción 4530
  4. Noticias Hisamitsu Pharmaceutical Co., Inc.
  5. Otros idiomas